• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 1314-1328 of 1,786 results

1044 Exhibit: Leyland Jones, Dose Scheduling Herceptin

Document IPR2017-00805, No. 1044-125 Exhibit - Leyland Jones, Dose Scheduling Herceptin (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

2021 Exhibit: Second Amended Notices of Deposition of Allan Lipton, MD

Document IPR2017-00805, No. 2021-61 Exhibit - Second Amended Notices of Deposition of Allan Lipton, MD (P.T.A.B. Dec. 22, 2017)

cite Cite Document
Analyze

1051 Exhibit: US Provisional Application No 60 151,018

Document IPR2017-00805, No. 1051-131 Exhibit - US Provisional Application No 60 151,018 (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

1043 Exhibit: Leyland Jones, Pharmacological Insights into the Future of Herceptin

Document IPR2017-00805, No. 1043-124 Exhibit - Leyland Jones, Pharmacological Insights into the Future of Herceptin (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

2073 Exhibit: Corrected Exhibit Spiegel 1997

Document IPR2017-00805, No. 2073-118 Exhibit - Corrected Exhibit Spiegel 1997 (P.T.A.B. Jan. 16, 2018)

cite Cite Document
Analyze

2055 Exhibit: Hudziak 1989

Document IPR2017-00805, No. 2055-94 Exhibit - Hudziak 1989 (P.T.A.B. Dec. 22, 2017)

cite Cite Document
Analyze

2036 Exhibit: Osoba 1999

Document IPR2017-00805, No. 2036-76 Exhibit - Osoba 1999 (P.T.A.B. Dec. 22, 2017)

cite Cite Document
Analyze

2014 Exhibit: Declaration of Daralyn J Durie

Document IPR2017-00805, No. 2014-54 Exhibit - Declaration of Daralyn J Durie (P.T.A.B. Jun. 8, 2017)

cite Cite Document
Analyze

1015 Exhibit: 5 Phase II Study of Intravenous Recombinant

Document IPR2017-00805, No. 1015-15 Exhibit - 5 Phase II Study of Intravenous Recombinant (P.T.A.B. Jan. 30, 2017)

cite Cite Document
Analyze

1027 Exhibit: EPA Exposure Factors Handbook

Document IPR2017-00805, No. 1027-29 Exhibit - EPA Exposure Factors Handbook (P.T.A.B. Jan. 30, 2017)

cite Cite Document
Analyze

1061 Exhibit: Exhibit 1061 CORRECTED Library of Congress Copyright Record for ...

Document IPR2017-00805, No. 1061-149 Exhibit - Exhibit 1061 CORRECTED Library of Congress Copyright Record for Leyland Jones 03 (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

1045 Exhibit: Leyland Jones, Pharmacologic insights into the future of trastuzumab

Document IPR2017-00805, No. 1045-126 Exhibit - Leyland Jones, Pharmacologic insights into the future of trastuzumab (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

1042 Exhibit: Coates, On the Receiving End Patient Perception of the Side effects ...

Document IPR2017-00805, No. 1042-123 Exhibit - Coates, On the Receiving End Patient Perception of the Side effects of Cancer Chemotherapy (P.T.A.B. Mar. 21, 2018)

cite Cite Document
Analyze

2002 Exhibit: Riethmuller 1992

Document IPR2017-00805, No. 2002-42 Exhibit - Riethmuller 1992 (P.T.A.B. May. 4, 2017)

cite Cite Document
Analyze

1014 Exhibit: Pegram 98 Phase II Study of Receptor Enhanced

Document IPR2017-00805, No. 1014-14 Exhibit - Pegram 98 Phase II Study of Receptor Enhanced (P.T.A.B. Jan. 30, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 88 89 90 91 92 ... >>